Blog - Page 2327 of 5627

MondayJan 08, 2018 1:34 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Recaps 2017 Highlights

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, this morning announced the release of a 2017 year-end summary penned by CEO Chris Bunka. The release highlights what Bunka refers to as Lexaria’s “busiest and most productive” year to date, including details about the company’s progress toward strengthening its balance sheet, ongoing research and development efforts related to its patented DehydraTECH™ absorption and palatability enhancing technology, its preparations for increased demand in both Californian and Canadian markets and its ongoing efforts to strengthen its intellectual property portfolio. Bunka…

MondayJan 08, 2018 1:28 pm

QualityStocksNewsBreaks – NeutriSci International Inc. (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) Enters Research and Development MOU with Scientus Pharma Inc.

NeutriSci International (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) this morning announced that it has entered into a major research and development (R&D) Memorandum of Understanding (“MOU”) with Scientus Pharma Inc. In accordance of the terms set forth in the MOU, the two companies have agreed to share their technologies to develop, test, produce, and distribute a medical cannabinoid product for current retail distribution networks throughout Canada. "This Scientus Pharma partnership helps position us at the forefront of developing new and innovative cannabinoid based medical products in Canada. Scientus Pharma, along with its existing partnerships, is sure to be a dominant…

MondayJan 08, 2018 12:57 pm

QualityStocksNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Launches CBD TV YouTube Channel

Grey Cloak Tech, Inc. (OTCQB: GRCK) this morning announced the launch of its brand new YouTube channel, CBD TV, which will feature content such as educational videos on CBD, in-house staff video reviews of products found on CBD.co and interviews with some of the top executives in the CBD and hemp arenas. Per the update, CBD TV, which can be visited at www.CBD.co/tv, will be one of the chief communication tools for the Grey Cloak family of companies moving forward. “Frankly, there is no “go-to” source of reliable information on CBD or hemp on the web. Thus, it’s a great…

MondayJan 08, 2018 12:31 pm

QualityStocksNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Utilizes Caribbean Blue Scorpion Venom in Proprietary CELLB9®

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is developing Nature Identical™ peptides derived from Caribbean Blue Scorpion venom to treat, regulate and prevent cancer progression. An article discussing this reads: “The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been…

MondayJan 08, 2018 12:05 pm

QualityStocksNewsBreaks – Medical Cannabis Payment Solutions (REFG) Issues Response following Attorney General’s Decision to Rescind Cole Memo

Cannabis-focused financial services company Medical Cannabis Payment Solutions (OTC: REFG) this morning issued a response to Attorney General Jeff Sessions’ decision to rescind the Cole Memo and other internal enforcement guidelines from the Obama Administration that deprioritized enforcement of federal marijuana prohibition against individuals and businesses complying with state laws regarding marijuana. “Our company relied on the Cole Memo and the supplementary Treasury Department guidance in our company’s business strategy,” Jeremy Roberts, CEO of Medical Cannabis Payment Solutions, stated in the news release. “We also rely on the protections of the Rohrabacher-Farr Amendment. We believe that while the Cole Memo…

MondayJan 08, 2018 10:15 am

QualityStocksNewsBreaks – IEG Holdings Corp. (IEGH) Commences Tender Offer for Stake in LendingClub Corporation (NYSE: LC), Highlights “Flawed” Business Model

Consumer loan provider IEG Holdings Corp. (OTCQB: IEGH) this morning announced the commencement of a tender offer for shares of LendingClub Corporation (NYSE: LC) by which the company aims to exchange 13 shares of its common stock for each share of LendingClub, up to an aggregate of just over 20 million shares, or 4.99 percent of LendingClub’s outstanding shares. In the news release, IEGH identified what it believes to be a number of major risks and problems with the LendingClub business model and management, including weak underwriting standards, lack of company-owned state lending licenses, unsustainable funding sources, excessive cost structure…

FridayJan 05, 2018 5:58 pm

QualityStocksNewsBreaks – IEG Holdings Corp. (IEGH) Initiates Tender Offer for Shares of LendingClub Corp. (NYSE: LC)

IEG Holdings (OTCQB: IEGH), a provider of unsecured consumer loans, said today that it has commenced a tender offer to exchange 13 shares of the company’s common stock for each share of common stock of LendingClub Corp. (NYSE: LC) up to a total of 20,701,999 shares of LendingClub common stock. The aggregate amount represents approximately 4.99% of LendingClub’s outstanding shares as of October 31, 2017, validly tendered and not properly withdrawn in the offer. Unless it is extended further or terminated early, this offer is set to expire on February 22 at 5 p.m. ET. Complete terms and conditions of…

FridayJan 05, 2018 4:26 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is “One to Watch”

Developing Nature Identical™ peptides derived from Caribbean Blue Scorpion venom to treat, regulate and prevent cancer progression Global market for cancer treatments projected to reach $161.3 billion by 2021 Unique Sol-gel nose-to-brain CBD delivery platform under development to provide clinical relief of various physical disorders Global neuropathic pain market estimated at $8.3 billion by 2024 Proof of concept already demonstrated for dual-gene therapy for type 2 diabetes and obesity Global expenditure for diabetes market in 2016 reached $825 billion PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to…

FridayJan 05, 2018 1:04 pm

SinglePoint, Inc. (SING) Poised to Unite Booming Markets with Comprehensive Solutions

SING at the forefront of $24.5 billion legal cannabis industry and rapidly-growing cryptocurrency market The company plans full launch of its proprietary bitcoin-powered credit-debit payment processing platform and end-to-end solutions Recent and planned key acquisitions and joint ventures will strengthen SING’s position in booming markets As a pioneering and innovative company that offers mobile, technology-driven solutions in various markets, including those to be considered high-risk, SinglePoint, Inc. (OTC: SING) is at the forefront of booming sectors including the legal cannabis industry and the cryptocurrency market. With legal marijuana sales projected to reach upward of $24.5 billion by 2021 (http://dtn.fm/ELz0j), coupled…

FridayJan 05, 2018 1:00 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) Could Create Non-opioid Pain Solution for Rising Population of Senior Citizens

Skinvisible (OTCQB: SKVI), a topical and transdermal product development company, recently entered a non-binding merger with Quoin Pharmaceuticals Limited. The two companies are expected to deliver a non-opioid solution to pain sufferers. An article discussing this reads: “Health professionals are preparing for an expected doubling of the 65 years and older population within the next 30 years, creating medical need to address the pain that often becomes a prevalent companion to age. While modern pharmaceuticals have developed opioids and non-steroidal therapies for reducing chronic pain, the drugs are often accompanied by addiction and unwanted side effect concerns. However, Skinvisible, Inc.’s…

Site Search

Company Search